Biocodex Deal History & Licensing Activity
Biocodex is a life sciences. The company currently has 7 active clinical trials, primarily in CNS Disorders.
Deals (12mo)
1
Active Trials
7
Top Modality
N/A
Focus Area
CNS Disorders
Biocodex Pipeline Focus
Therapeutic areas and modalities where Biocodex is most active based on deal history and clinical trial data.
Therapeutic Areas
Biocodex Clinical Pipeline
Biocodex has 7 active clinical trials across 4 development phases.
2
Not Applicable
1
Phase 4
2
Phase 2
2
Phase 3
See How Your Asset Matches Biocodex's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for CNS Disorders assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
About Biocodex Licensing & Deal Activity
Biocodex is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape.
Key therapeutic areas of focus for Biocodex include CNS Disorders (2 deals and trials).
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Biocodex and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Biocodex's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.